By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Celsis In Vitro Technologies 

1450 South Rolling Road

Baltimore  Maryland  21227  U.S.A.
Phone: 410-455-1242 Fax: 410-455-1245


SEARCH JOBS

Celsis In Vitro Technologies offers a full range of in vitro products for ADME-Tox applications. Our products reflect our passion for quality, innovation and in many cases, proprietary methods.

- Hepatocytes
- Fresh human and animal hepatocytes
- Cryopreserved human and animal hepatocytes
- Plateable cryopreserved human hepatocytes
- LiverPool™ cryopreserved human hepatocytes
- InVitroGRO™ Media
- Microsomes and S9
- Caco-2.1™ Assay Kits
- Custom Products

Last Updated: 04-23-2007



Key Statistics


Email: info@invitrotech.com
Ownership: Public

Web Site: Celsis In Vitro Technologies
Employees:
Symbol: CEL.L
 



Industry
Pharmaceutical

Segment
Drug Discovery





Company News
VistaGen Therapeutics, Inc. Enters Strategic Collaboration With Celsis In Vitro Technologies (CEL.L) to Further Advance LiverSafe 3D™ 3/4/2013 9:44:26 AM
Celsis In Vitro Technologies (CEL.L) Announces Symposia and Poster Presentations at the 18th North American Regional ISSX Meeting 10/11/2012 9:49:01 AM
U.S. Court of Appeals for the Federal Circuit Court Upholds Celsis In Vitro Technologies (CEL.L) Injunction Against Life Technologies (LIFE) in LiverPool™ Patent Infringement Lawsuit 1/10/2012 6:40:19 AM
Celsis In Vitro Technologies (CEL.L) Wins Preliminary Injunction Against Life Technologies (LIFE) and CellzDirect in Liverpool(TM) Patent Infringement Lawsuit 9/13/2010 3:11:45 PM
Celsis In Vitro Technologies (CEL.L) Seeks Injunction Against Invitrogen Corporation (IVGN) for LiverPool(TM) Patent Infringement 7/1/2010 6:22:15 AM
Celsis In Vitro Technologies (CEL.L) Finds China Distributor 2/11/2010 11:26:50 AM
Celsis In Vitro Technologies (CEL.L) and Promega Biosciences, Inc. to Offer Fast, Reliable Solutions for ADME-Tox Testing With Primary Hepatocytes 2/12/2009 10:36:18 AM
Celsis In Vitro Technologies (CEL.L) Introduces New Assay-Specific Human Liver Microsomes 2/11/2008 11:03:28 AM
Celsis International PLC  (CEL.L) Acquires In Vitro Technologies For $30 Million 8/8/2006 10:27:37 AM
In Vitro Technologies Opens European Headquarters In Biosaxony10/19/2005 5:13:23 PM
//-->